Authors:
COUDERC B
ZITVOGEL L
DOUINECHINARD V
DJENNANE L
TAHARA H
FAVRE G
LOTZE MT
ROBBINS PD
Citation: B. Couderc et al., ENHANCEMENT OF ANTITUMOR IMMUNITY BY EXPRESSION OF CD70 (CD27 LIGAND)OR CD154 (CD40 LIGAND) COSTIMULATORY MOLECULES IN TUMOR-CELLS, Cancer gene therapy, 5(3), 1998, pp. 163-175
Authors:
DOUINECHINARD V
ROBBINS PD
LOTZE MT
FAVRE G
COUDERC B
Citation: V. Douinechinard et al., ENHANCEMENT OF ANTITUMOR IMMUNITY BY INJECTION OF FIBROBLASTS GENETICALLY-ENGINEERED TO PRODUCE IL-12 AND TO EXPRESS 2 COSTIMULATORY MOLECULES CD70 AND CD80, Cancer gene therapy, 4(5), 1997, pp. 320-320
Authors:
COHENJONATHAN E
TOULAS C
MONTEIL S
COUDERC B
MARET A
BARD JJ
PRATS H
DALYSCHVEITZER N
FAVRE G
Citation: E. Cohenjonathan et al., RADIORESISTANCE INDUCED BY THE HIGH-MOLECULAR FORMS OF THE BASIC FIBROBLAST GROWTH-FACTOR IS ASSOCIATED WITH AN INCREASED G(2) DELAY AND A HYPERPHOSPHORYLATION OF P34(CDC2) IN HELA-CELLS, Cancer research, 57(7), 1997, pp. 1364-1370
Authors:
SERONIEVIVIEN S
PRADINES A
COUDERC B
CLAMAGIRAND C
BERG D
SOULA G
FAVRE G
Citation: S. Seronievivien et al., REVERSION OF TRANSFORMED PHENOTYPE OF HUMAN ADENOCARCINOMA A549 CELLSBY EXPRESSION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE COMPLEMENTARY-DNA, Cell growth & differentiation, 6(11), 1995, pp. 1415-1425
Authors:
AMALRIC F
GALY B
COUDERC B
MARET A
PRATS AC
PRATS H
Citation: F. Amalric et al., EXPRESSION OF HUMAN FIBROBLAST GROWTH FACTOR-II AND CELL-TRANSFORMATION - SOME PARADOXICAL ASPECTS, Antibody immunoconjugates, and radiopharmaceuticals, 8(4), 1995, pp. 243-250
Citation: B. Couderc et al., TERM EFFECTS OF CALCIUM AVAILABILITY ON PROLACTIN AND PROTEIN-SYNTHESIS IN HUMAN DECIDUAL CELLS, Placenta, 16(6), 1995, pp. 527-537
Authors:
SERONIEVIVIEN S
COUDERC B
SOULA G
FAVRE G
Citation: S. Seronievivien et al., THE HMGCOA REDUCTASE-DNAC EXPRESSION INHI BITS THE TUMORAL PHENOTYPE OF A549 AND MCF7 HUMAN ADENOCARCINOMA CELLS, Bulletin du cancer, 81(11), 1994, pp. 962-963